The Press Release Resource

The knowledge of autoimmune neuropathies has increased significantly over the past years. Regardless, clinical routine diagnosis of autoimmune neuropathies did not keep pace with research and has not changed substantially. As a result, chronic autoimmune neuropathies are regularly misdiagnosed and mistreated, leaving the patient disabled. This is where the lab can render assistance by determination …

Cambridge, United Kingdom (April 11, 2011) – Novus Biologicals, an international supplier of antibodies and proteins to the bioresearch industry, reveal that NAVREFF had added them to their exclusive preference program. The National Association of Veterans’ Research and Education Foundation (NAVREF) is excited to add Novus Biologicals to the NAVREF Preferred Vendor Program.  As a …

PISCATAWAY, N.J., 22 Nov, 2010 – Internationally recognized biology contract research organization GenScript USA Inc. received the approval of Animal Welfare Assurance from the Office of Laboratory Animal Welfare (OLAW) of the U.S. National Institutes of Health (NIH) for its animal facility on 9 Nov, 2010. This Assurance is effective until 30 Nov 2015. GenScript …

Cambridge, England (May XX, 2010) – Novus Biologicals is excited to announce the release of a new Antibody Concentration and Clean Up Kit, for use with Lightning Link Antibody Labeling Kits.  This new kit allows researchers to use any antibody, regardless of the buffer or concentration, with Lightning Link Kits.  Antibodies are sometimes only available …

Cambridge, England (March 19, 2010) – Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, announce that they have launched the first TMEM97 antibody onto the market. The Novus Product Development Team is excited to announce the launch of a new antibody target not currently available by any other …

Cambridge, England (January 29, 2010) – Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, has recently taken steps to broaden and enhance their product offering to stem cell researchers. Novus recently constructed a new laboratory facility specifically designed for testing stem cell products at their headquarters in Littleton, …

GenScript will sponsor the BIT Life Sciences’ 1st Annual International Congress of Antibodies (ICA). CEO Dr. Frank Zhang will give keynote speech to share thoughts on antibody drug development.